CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Status Active, not recruiting

Clinical Trial Summary

CMV infection and disease remain a significant clinical challenge for pediatric solid organ transplant (SOT) recipients. Current prevention strategies are limited to prophylaxis in which antiviral medication is administered for a period of several months or preemption in which close monitoring of CMV viral load from the peripheral blood is performed and treatment is initiated when CMV is detected. Each of these strategies has risks, costs, and limitations associated with it. Recently, assays for measurement of an individual patient's CMV immunity have been developed and are clinically available. One of these is the Viracor CMV T cell Immunity Panel. This flow cytometry based assay is performed on peripheral blood and measures cytokine release in response to CMV antigen stimulation by flow cytometry. The thresholds for this assay that confer protection against CMV infection in pediatric SOT recipients are not known. Defining CMV-specific cell mediated immune response thresholds that confer protection against CMV reactivation could inform patient specific durations of antiviral prophylaxis or pre-emptive surveillance testing. Therefore, the objective of this study is to quantify CMVresponsive T lymphocyte populations by flow cytometry (Viracor CMV T cell Immunity Panel) in pediatric heart, kidney, and liver transplant recipients within the first year of transplantation and to investigate potential threshold values that correlate with protection against CMV infection (DNAemia).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03924219
Study type	Observational
Source	Vanderbilt University Medical Center
Contact
Status	Active, not recruiting
Phase
Start date	June 3, 2019
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02439957` - A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus	Phase 3
Not yet recruiting	`NCT06364618` - Use of Wearables to Detect Infections in Kidney Transplant Recipients
Completed	`NCT05142748` - Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital
Terminated	`NCT05747053` - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed	`NCT03339661` - Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.	Phase 2
Enrolling by invitation	`NCT05224583` - Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
Recruiting	`NCT04701528` - Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients	Phase 2
Recruiting	`NCT04494776` - SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
Completed	`NCT02263703` - Immunogenicity of HPV Vaccine in Immunosuppressed Children	Phase 3
Recruiting	`NCT06219616` - Prediction of BK Virus Reactivation in Kidney Transplant Recipient	N/A
Not yet recruiting	`NCT05708534` - Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Recruiting	`NCT03488771` - Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients
Recruiting	`NCT04815954` - Early vs Late Urinary Catheter Removal After Renal Transplantation	N/A
Recruiting	`NCT05727709` - Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Completed	`NCT04542954` - Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Recruiting	`NCT05836636` - Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
Completed	`NCT03468478` - Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation	Phase 4
Recruiting	`NCT05397821` - Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
Not yet recruiting	`NCT05316038` - Metabolic and Infectious Complications Post Belatacept Conversion
Active, not recruiting	`NCT04747522` - Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)